Targeting Cirrhosis & Fibrotic Complications To Improve Translational Relevance, Enable Late-Stage Intervention & Expand Therapeutic Impact In Mash

• Targeting cirrhotic progression and fibrotic complications to improve translational understanding of advanced disease, enabling more clinically relevant therapeutic development
• Developing preclinical strategies focused on cirrhosis-associated pathways to improve intervention opportunities, strengthening late-stage treatment potential and translational applicability
• Expanding therapeutic focus beyond early fibrosis to address advanced MASH populations, improving long-term clinical impact and future treatment opportunities

Speakers:

Yury Popov

Associate Professor of Medicine & Director, Liver Fibrosis Research

Beth Israel Deaconess Medical Center